Autonomous Artificial Intelligence in Diabetic Retinopathy: From Algorithm to Clinical Application.

Publications // Roomasa Channa // May 01 2021

PubMed ID: 32126819

Author(s): Channa R, Wolf R, Abramoff MD. Autonomous artificial intelligence in diabetic retinopathy: from algorithm to clinical application. J Diabetes Sci Technol. 2021 May;15(3):695-698. doi: 10.1177/1932296820909900. Epub 2020 Mar 4. PMID 32126819

Journal: Journal Of Diabetes Science And Technology, Volume 15, Issue 3, May 2021

Artificial intelligence (AI)-based algorithms are rapidly entering the health care field and have the potential to improve patient care. Our article focuses on the use of autonomous AI algorithms (ie, algorithms that can make clinical decisions without human oversight) in diagnostic imaging. In this article, we have used the example of diabetic retinopathy screening to highlight some important aspects to be considered by developers, policymakers, and end users when bringing autonomous AI algorithms into clinical practice. We have divided these aspects into (1) following the principles of safety, efficacy, and equity in all phases of development and implementation of the algorithm; (2) regulatory processes involving medical records, medical liability, and patient privacy; (3) cost and billing; and (4) the role of health care providers.